Misty Copeland changed what was possible for generations of dancers to come. Jim and Kate sit down with Misty to talk about the determination it took to reach the top and why her focus today is on creating opportunity for others. They discuss motherhood and the work she's doing through The Misty Copeland Foundation to help young artists see themselves in spaces where they belong. This is a conversation about building something bigger than yourself.

See omnystudio.com/listener for privacy information.

For Maimah Karmo, surviving cancer was just the beginning. In this episode of Get Real, Jim sits down with Maimah, founder and CEO of the Tigerlily Foundation, who is 20 years out from a diagnosis of stage two triple negative breast cancer. Maimah made a decision early on: she wasn’t just going to survive, she was going to live with intention. She shares how her upbringing, from Liberia to building a life in the U.S., shaped her instinct to advocate for herself and others. And how, after her first chemotherapy treatment, she began building Tigerlily with nothing but a question, a prayer, and a purpose. They get real about what it means to thrive after cancer — physically, mentally, and emotionally. From daily practices to discipline to building community. Maimah shows that longevity isn’t just about time.It’s about how you choose to live it.

See omnystudio.com/listener for privacy information.

For decades, the biotech industry has been concentrated in a handful of coastal hubs. But according to Isaac Barchas, one of the most significant opportunities in medicine may be hiding in plain sight.In this episode of Get Real, Jim Weiss sits down with Isaac Barchas, co-founder of Arsenal Bridge Ventures, to discuss why world-class scientific research is happening far beyond Boston and Silicon Valley, and why investors have been overlooking it for years.Isaac shares Arsenal Bridge's mission to identify breakthrough discoveries emerging from universities and research institutions across America's heartland, provide the capital and leadership needed to commercialize them, and help transform promising science into life-changing therapies.Together, Jim and Isaac explore the future of biotech innovation, the challenges of building companies outside traditional venture capital hubs, and why investing in overlooked regions could be good for patients, good for business, and good for America.

See omnystudio.com/listener for privacy information.